Avinger, Inc. (AVGR)
NASDAQ: AVGR · IEX Real-Time Price · USD
1.730
-0.040 (-2.26%)
Jul 22, 2024, 9:58 AM EDT - Market open
Avinger Employees
As of December 31, 2023, Avinger had 72 total employees, including 68 full-time and 4 part-time employees. The number of employees decreased by 3 or -4.00% compared to the previous year.
Employees
72
Change (1Y)
-3
Growth (1Y)
-4.00%
Revenue / Employee
$105,875
Profits / Employee
-$224,056
Market Cap
3.43M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Venus Concept | 304 |
Xylo Technologies | 84 |
Fresh2 Group | 75 |
Applied DNA Sciences | 55 |
Aptevo Therapeutics | 40 |
Scinai Immunotherapeutics | 31 |
Enveric Biosciences | 7 |
Qualigen Therapeutics | 4 |
AVGR News
- 4 weeks ago - Avinger Announces Closing of up to $24 Million Public Offering - Accesswire
- 5 weeks ago - Avinger Announces Pricing of up to $24 Million Public Offering - Accesswire
- 6 weeks ago - Avinger Increases Focus on Coronary Development, Reduces Operating Costs of Peripheral Business - Accesswire
- 2 months ago - Avinger Announces Conversion of $11 Million of CRG Debt into Preferred Equity - Accesswire
- 2 months ago - Avinger Reports First Quarter 2024 Results - Accesswire
- 2 months ago - Avinger to Announce First Quarter 2024 Results on May 15, 2024 - Accesswire
- 4 months ago - Avinger Reports Fourth Quarter and Full Year 2023 Results - Accesswire
- 4 months ago - Avinger to Announce Full Year 2023 Results on March 20, 2024 - Accesswire